Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-03-01 @ 8:55 PM
Study NCT ID:
NCT02970669
Status:
COMPLETED
Last Update Posted:
2021-10-07
First Post:
2016-11-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Heart Failure, Reduced Ejection Fraction | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Heart failure with reduced left ventricular ejection fraction (LVEF) | View |
| None | Cardiac dysfunction | View |
| None | Heart muscle dysfunction | View |
| None | Left ventricular (LV) dilation | View |
| None | Left ventricular hypertrophy | View |
| None | HF | View |
| None | AHF | View |
| None | CHF | View |
| None | acute heart failure | View |
| None | chronic heart failure | View |
| None | congestive heart failure | View |
| None | congestive cardiac failure | View |
| None | Heart failure | View |
| None | HReEF | View |
| None | Physical Activity | View |
| None | Actigraphy | View |
| None | Home sleep test | View |
| None | wake | View |